Mount Yale Investment Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Mount Yale Investment Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,871	Closed	-$133K	–	1395
2025 Q2	$133K	Buy	+8,871	New	+$127K	0.01%	612
2023 Q4	–	Sell	-33,505	Closed	-$448K	–	534
2023 Q3	$448K	Buy	+33,505	New	+$453K	0.05%	321
2023 Q2	–	Sell	-18,230	Closed	-$208K	–	510
2023 Q1	$208K	Buy	+18,230	New	+$197K	0.02%	456
2018 Q4	–	Sell	-3,000	Closed	-$21K	–	669
2018 Q3	$21K	Hold	3,000	–	–	﹤0.01%	773
2018 Q2	$19K	Sell	3,000 -3,500	-54%	-$22.1K	﹤0.01%	809
2018 Q1	$42K	Buy	+6,500	New	+$45.6K	0.01%	644

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mount Yale Investment Advisors's RDY Position: Q3 2025 in Review

Mount Yale Investment Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 8,871 shares — an estimated $133K sold.

Mount Yale Investment Advisors first reported a position in RDY in Q1 2018 and held it in 6 quarters. The position peaked at $448K in Q3 2023. 227 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

Mount Yale Investment Advisors reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
Mount Yale Investment Advisors sold 8,871 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $133K.
Mount Yale Investment Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2018 and held it in 6 quarters.
Mount Yale Investment Advisors's Dr. Reddy's Laboratories position peaked at $448K in Q3 2023.
227 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.